Arkansas’ $1.25 Billion Risperdal Trial Starts Today

Kermit Cole
1
44

Arkansas’ lawsuit against Johnson & Johnson for false and misleading claims regarding Risperdal is set to begin today, the fourth time J&J has a faced a state’s complaints about the drug. Arkansas is accusing J&J of hiding the serious health risks of Risperdal, and of promoting it for unapproved uses such as the treatment of dementia and Alzheimer’s disease, despite evidence that the drug increased the risk of death in elderly patients. The minimum penalty of $5,000 per prescription would total an award of $1.25 billion.

Article → 

Previous articleWhat is in a Name: One Psychiatrist’s View of Psychiatric Diagnosis
Next articleHow Technology Worship Keeps Americans Ignorant about Depression Treatment
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]

1 COMMENT

  1. I saw my friend who was a capable person change so much that she was not able to do simple things a child could do when she was forced to take Risperdal. Eventually they forgot to give her the last injection before she returned home alone for Christmas. She took her life soon afterwards. I believe her suicide was a result of the withdrawal from this toxic drug.